Literature DB >> 11141497

Staging of neurofibrillary degeneration caused by human tau overexpression in a unique cellular model of human tauopathy.

G F Hall1, V M Lee, G Lee, J Yao.   

Abstract

The hyperphosphorylation of human tau and its aggregation into neurofibrillary tangles are central pathogenic events in familial tauopathies and Alzheimer's disease. However, the cellular consequences of neurofibrillary tangle formation in vivo have not been directly studied because cellular models of human neurofibrillary degeneration have been unavailable until recently. Incorporation of human tau into filaments in vivo and the association of filamentous tau with cytodegeneration were first demonstrated experimentally with the overexpression of human tau in identified neurons (anterior bulbar cells) in the lamprey central nervous system. In this system, filamentous tau deposits are associated with the loss of dendritic microtubules and synapses, plasma membrane degeneration, and eventually the formation of extracellular tau deposits and cell death. Here we show that human tau hyperphosphorylation in anterior bulbar cells is spatiotemporally correlated with a highly stereotyped sequence of degenerative stages closely resembling those seen in human neurofibrillary degeneration. Hyperphosphorylated tau deposits first appear in the distal dendrites and somata, together with degenerative changes that begin in distal dendrites and progress proximally over time. This sequence is independent of the tau isoform used, the presence of epitope tags and the method used to overexpress tau, and thus has important implications for the cytopathogenesis of human neurofibrillary disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11141497      PMCID: PMC1850256          DOI: 10.1016/S0002-9440(10)63962-4

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  50 in total

1.  Axotomy-induced neurofilament phosphorylation is inhibited in situ by microinjection of PKA and PKC inhibitors into identified lamprey neurons.

Authors:  G F Hall; K S Kosik
Journal:  Neuron       Date:  1993-04       Impact factor: 17.173

Review 2.  Cellular responses of identified lamprey central neurons to axonal and dendritic injury. An in situ model for studying cellular injury on the single cell level in the vertebrate CNS.

Authors:  G F Hall
Journal:  Ann N Y Acad Sci       Date:  1993-05-28       Impact factor: 5.691

3.  Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding.

Authors:  G T Bramblett; M Goedert; R Jakes; S E Merrick; J Q Trojanowski; V M Lee
Journal:  Neuron       Date:  1993-06       Impact factor: 17.173

Review 4.  Intracellular APP processing and A beta production in Alzheimer disease.

Authors:  C A Wilson; R W Doms; V M Lee
Journal:  J Neuropathol Exp Neurol       Date:  1999-08       Impact factor: 3.685

5.  Overexpression of four-repeat tau mRNA isoforms in progressive supranuclear palsy but not in Alzheimer's disease.

Authors:  C B Chambers; J M Lee; J C Troncoso; S Reich; N A Muma
Journal:  Ann Neurol       Date:  1999-09       Impact factor: 10.422

6.  On the survival time of a tangled neuron in the hippocampal CA4 region in parkinsonism dementia complex of Guam.

Authors:  C Schwab; M Schulzer; J C Steele; P L McGeer
Journal:  Neurobiol Aging       Date:  1999 Jan-Feb       Impact factor: 4.673

7.  In vitro polymerization of oxidized tau into filaments.

Authors:  J C Troncoso; A Costello; A L Watson; G V Johnson
Journal:  Brain Res       Date:  1993-06-11       Impact factor: 3.252

8.  Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: distinction between PHF-like immunoreactivity and microtubule binding.

Authors:  J Biernat; N Gustke; G Drewes; E M Mandelkow; E Mandelkow
Journal:  Neuron       Date:  1993-07       Impact factor: 17.173

9.  Assembly of Alzheimer-like filaments from full-length tau protein.

Authors:  R A Crowther; O F Olesen; M J Smith; R Jakes; M Goedert
Journal:  FEBS Lett       Date:  1994-01-10       Impact factor: 4.124

10.  Alzheimer-like paired helical filaments and antiparallel dimers formed from microtubule-associated protein tau in vitro.

Authors:  H Wille; G Drewes; J Biernat; E M Mandelkow; E Mandelkow
Journal:  J Cell Biol       Date:  1992-08       Impact factor: 10.539

View more
  19 in total

1.  Neurodegenerative tauopathy in the worm.

Authors:  Michel Goedert
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-11       Impact factor: 11.205

Review 2.  Dendritic vulnerability in neurodegenerative disease: insights from analyses of cortical pyramidal neurons in transgenic mouse models.

Authors:  Jennifer I Luebke; Christina M Weaver; Anne B Rocher; Alfredo Rodriguez; Johanna L Crimins; Dara L Dickstein; Susan L Wearne; Patrick R Hof
Journal:  Brain Struct Funct       Date:  2010-02-24       Impact factor: 3.270

3.  Exosome-associated tau is secreted in tauopathy models and is selectively phosphorylated in cerebrospinal fluid in early Alzheimer disease.

Authors:  Sudad Saman; WonHee Kim; Mario Raya; Yvonne Visnick; Suhad Miro; Sarmad Saman; Bruce Jackson; Ann C McKee; Victor E Alvarez; Norman C Y Lee; Garth F Hall
Journal:  J Biol Chem       Date:  2011-11-04       Impact factor: 5.157

4.  Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice.

Authors:  H L Melrose; J C Dächsel; B Behrouz; S J Lincoln; M Yue; K M Hinkle; C B Kent; E Korvatska; J P Taylor; L Witten; Y-Q Liang; J E Beevers; M Boules; B N Dugger; V A Serna; A Gaukhman; X Yu; M Castanedes-Casey; A T Braithwaite; S Ogholikhan; N Yu; D Bass; G Tyndall; G D Schellenberg; D W Dickson; C Janus; M J Farrer
Journal:  Neurobiol Dis       Date:  2010-07-24       Impact factor: 5.996

5.  Multiple mechanisms of extracellular tau spreading in a non-transgenic tauopathy model.

Authors:  Meghan N Le; Wonhee Kim; Sangmook Lee; Ann C McKee; Garth F Hall
Journal:  Am J Neurodegener Dis       Date:  2012-11-25

Review 6.  The intersection of amyloid β and tau in glutamatergic synaptic dysfunction and collapse in Alzheimer's disease.

Authors:  Johanna L Crimins; Amy Pooler; Manuela Polydoro; Jennifer I Luebke; Tara L Spires-Jones
Journal:  Ageing Res Rev       Date:  2013-03-22       Impact factor: 10.895

7.  Tau Mislocation in Glucocorticoid-Triggered Hippocampal Pathology.

Authors:  Sara Pinheiro; Joana Silva; Cristina Mota; João Vaz-Silva; Ana Veloso; Vítor Pinto; Nuno Sousa; João Cerqueira; Ioannis Sotiropoulos
Journal:  Mol Neurobiol       Date:  2015-09-02       Impact factor: 5.590

8.  Small-molecule mediated neuroprotection in an in situ model of tauopathy.

Authors:  Nicolette S Honson; Jordan R Jensen; Aida Abraha; Garth F Hall; Jeff Kuret
Journal:  Neurotox Res       Date:  2009-02-26       Impact factor: 3.911

9.  Neurofibrillary degeneration can be arrested in an in vivo cellular model of human tauopathy by application of a compound which inhibits tau filament formation in vitro.

Authors:  Garth F Hall; Sangmook Lee; Jun Yao
Journal:  J Mol Neurosci       Date:  2002-12       Impact factor: 3.444

10.  Animal models for Alzheimer's disease and frontotemporal dementia: a perspective.

Authors:  Jürgen Götz; Naeman N Götz
Journal:  ASN Neuro       Date:  2009-11-09       Impact factor: 4.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.